Antibody validation for reproducible flow cytometry analysis [WEBINAR]

Поділитися
Вставка
  • Опубліковано 21 жов 2024
  • For more information, visit www.miltenyibi... Mona Al-Maarri highlights how Miltenyi Biotec’s antibody validation efforts improve quality and reproducibility in flow cytometry experiments. In this 30-minute webinar, you will learn about:
    The antibody-related reproducibility crisis
    Common causes of low reproducibility in flow cytometry experiments and lot-to-lot variations of
    antibody reagents
    Recombinant antibodies and how they contribute to reproducibility
    Quality control and validation steps employed in Miltenyi Biotec´s antibody production
    Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,500 employees in over 25 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

КОМЕНТАРІ • 3

  • @shyamyadav5133
    @shyamyadav5133 Рік тому +2

    Thanks for sharing 🙏

  • @layas8690
    @layas8690 3 роки тому +1

    Are these antibodies CE-IVD validated for clinical use?

    • @Miltenyi_Biotec
      @Miltenyi_Biotec  3 роки тому

      Hi LAYAS, MACS IVD Antibodies are for in vitro diagnostic use, and are not intended for human in vivo applications. In the EU, MACS IVD Antibodies are available as CE-marked in vitro diagnostic medical devices and meet the requirements of the European directive 98/79/EC on in vitro diagnostic medical devices (IVDD). MACS IVD Antibodies are designed and manufactured under a quality system certified to ISO 13485. These products are not available for use in the United States. If you have further question please contact our Technical Support Team technicalsupport@miltenyi.com